Patents by Inventor Thadd C. Reeder

Thadd C. Reeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240285221
    Abstract: A detection function is used to detect an event in an electroencephalogram (EEG) signal in order to generate a plurality of detected events. For each detected event in the plurality of detected events, a plurality of features from the EEG signal is measured in order to obtain a measured feature vector, where the plurality of features is defined by a feature space corresponding to the event and a measured feature space includes a plurality of measured feature vectors corresponding to a plurality of labeled points having locations. The EEG signal is classified based at least in part on the locations of the plurality of labeled points in the measured feature space.
    Type: Application
    Filed: February 26, 2024
    Publication date: August 29, 2024
    Inventors: Daniel Korenblum, Thadd C. Reeder
  • Publication number: 20030172390
    Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising mutations in a Mo54 gene. Such transgenic mice are useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions.
    Type: Application
    Filed: September 23, 2002
    Publication date: September 11, 2003
    Inventors: Robert G. Wisotzkey, Thadd C. Reeder
  • Publication number: 20030066098
    Abstract: The present invention relates to compositions and methods relating to the characterization of gene function. More particularly, the present invention relates to the role of secreted protein genes involved in neurobiological disorders, and in particular, depression. In addition, the present invention provides transgenic mice comprising mutations in a secreted protein gene. Such transgenic mice are useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions, including depression.
    Type: Application
    Filed: November 5, 2001
    Publication date: April 3, 2003
    Inventors: Russell Phillips, Thadd C. Reeder, Keith D. Allen
  • Publication number: 20030056239
    Abstract: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising mutations in a NMP35 gene. Such transgenic mice are useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions.
    Type: Application
    Filed: June 25, 2002
    Publication date: March 20, 2003
    Inventors: Thadd C. Reeder, Russell Phillips